1478877

ORLISTAT RELATED COMPOUND D SOLUTION

United States Pharmacopeia (USP) Reference Standard

• 동의어(들): N-Formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester
• 실험식(Hill 표기법): C₂₉H₅₃NO₅
• CAS Number: 130793-27-0
• Molecular Weight: 495.73
• MDL number: MFCD28137837
• UNSPSC 코드: 41116107
• NACRES: NA.24

속성

• Grade: pharmaceutical primary standard
• Agency: USP
• API family: orlistat
• 제조업체/상표: USP
• 응용 분야: pharmaceutical
• 형식: neat
• SMILES string: N([C@@H](CC(C)C)C(=O)O[C@H]1[C@@H](C(=O)O[C@H](C1)CCCCCCCCCCC)CCCCCC)C=O
• InChI: 1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24-21-27(25(28(32)34-24)19-17-10-8-6-2)35-29(33)26(30-22-31)20-23(3)4/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27+/m0/s1
• InChI key: IYWNIYFHQZQPBP-YIPNQBBMSA-N

설명

일반 설명

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

애플리케이션

Orlistat Related Compound Solution USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Orlistat
• Orlistat Capsules

분석 메모

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

기타 정보

Sales restrictions may apply.

안전성 정보

• 픽토그램: GHS02,GHS07
• 신호어: Danger
• 유해 및 위험 성명서: H225,H302 + H312 + H332,H319
• 예방조치 성명서: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Storage Class Code: 3 - Flammable liquids
• WGK: WGK 2
• Flash Point (°F): 35.6 °F - closed cup
• Flash Point (°C): 2.0 °C - closed cup